The company plans to deploy cash in ways that boost investor exposure to HYPE on a per-share basis, prioritizing capital…
Read More
Sonnet BioTherapeutics Adjourning Special Meeting to Increase Stockholder Participation in Business Combination with Hyperliquid Strategies Inc.
PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced…
Read More
